Medical - Specialties industry analysis: EL7 Score and the best stocks ranked by value, profitability, and momentum.
Ranked among 4 stocks with a market cap above $500M. Smaller companies are excluded from the ranking.
Rank | Company | Price | P/E | Value | Growth | Quality | EL7 Score |
|---|---|---|---|---|---|---|---|
| 1/4 | ![]() | $129.25 | 153.9 | 46 | 65 | 88 | 92 |
| 2/4 | ![]() | $69.42 | 53.4 | 65 | 62 | 79 | 88 |
| 3/4 | ![]() | $228.49 | 27.9 | 81 | 73 | 67 | 85 |
| 4/4 | ![]() | $13.59 | — | 96 | 12 | 33 | 15 |
Score = market-cap-weighted percentile rank of the sector stocks vs the whole market (0-100). Higher = stronger.
76 of 152
P/E 27.9 vs period average 29.3 Cheaper than its history
Score = market-cap-weighted percentile rank of the sector stocks vs the whole market (0-100). Higher = stronger.
Insider purchases in the sector's stocks
Funds that track the sector and each fund's exposure to it.
Fund | Exposure | Assets | Expense |
|---|---|---|---|
| IBBiShares Biotechnology ETF | 100.0% | $11B | 0.44% |
| VHTVanguard Health Care ETF | 100.0% | $22B | 0.09% |
| IHIiShares U.S. Medical Devices ETF | 99.7% | $4B | 0.37% |
| XLVState Street Health Care Select Sector SPDR ETF | 99.1% | $47B | 0.08% |
The percentage is the sector's share of the fund's assets, per the latest available data.
Upgrades and downgrades on the sector's stocks